Verseon使用加密的AI科技 安全地加速癌症和心脏病的药物研究。 Verseon uses encrypted AI tech to securely accelerate drug research for cancer and heart disease.

Verseon生物技术公司为AITM采用了DataKrypto的FHENOM,利用完全同质加密和可信赖的执行环境,在培训和使用期间对医疗数据和AI模型进行加密。 Biotech firm Verseon has adopted DataKrypto’s FHEnom for AI™, leveraging fully homomorphic encryption and trusted execution environments to keep medical data and AI models encrypted during training and use. 该技术能够进行安全、合规的AI驱动研究,而不解密敏感信息,支持更快地发展癌症和心血管疾病治疗。 The technology enables secure, compliant AI-driven research without decrypting sensitive information, supporting faster development of treatments for cancer and cardiometabolic diseases. 解决方案允许无缝整合和快速部署,帮助Verseon注重科学创新,同时防止数据被破坏和模式被滥用。 The solution allows seamless integration and rapid deployment, helping Verseon focus on scientific innovation while protecting against data breaches and model misuse.